Deep Brain Stimulator Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Deep Brain Stimulator Market
Deep Brain Stimulator Market: By Product (Single, & Dual), By Application (Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Depression, Dystonia, and Parkinsons Disease), By End-User, & By Region-Forecast (2016-2021)
Report Code : HCR 0238
Published: 08 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Deep Brain Stimulator is a battery-operated medical device called neurostimulator, used in neosurgical procedure which helps to treat a variety of disabling neurological symptoms. Globally, development of technologically advanced product including electric current fractionated implantable pulse generator (IPG), rise in the incidence of Parkinson’s disease, growing R&D pertaining to deep brain stimulators are the prime growth drivers of global deep brain stimulator market. In addition, increase in adoption of deep brain stimulator and emerging economies such as China, India and others, will create new opportunities for global deep brain stimulator market. However, higher cost of research and development, risk of allergic reaction to the DMS parts in case of DMS placement, increased risk of infection are the key restraints for global deep brain stimulator market.

This report identifies the global deep brain stimulator market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global deep brain stimulator market.
 
Deep Brain Stimulator Market

Geographically North America dominated global deep brain stimulator market due to reimbursement policies and sophisticated healthcare infrastructure. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing disposable income & healthcare expenditure, rise in awareness levels and modernizing healthcare infrastructure in developing nations such as China and India in this region. Among all the end-users, hospitals has the highest market share in global deep brain stimulator market.

This report segments global deep brain stimulator market on the basis of type, application, end-user, and regional market as follows:
  • Deep Brain Stimulator Market, By Type: Single Channel Deep Brain Stimulator, and Dual Channel Deep Brain Stimulator
  • Deep Brain Stimulator Market, By Application: Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Depression, Dystonia, and Parkinsons Disease
  • The report has focused study on deep brain stimulator market by basis of end-user such as: Hospitals, Ambulatory Surgical Centers, and Neurological Clinics
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the deep brain stimulator market. Some of the major companies’ profiles in detail are as follows:
  • St. Jude Medical
  • Functional Neuromodulation
  • Medtronic INC.
  • Aleva Neurotherapeutics SA
1. Deep Brain Stimulator Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Deep Brain Stimulator Market– Market Forces
   4.1. Drivers
      4.1.1. Development of technologically advanced product including electric current fractionated implantable pulse generator (IPG)
      4.1.2. Rise in the incidence of Parkinson’s disease
      4.1.3. Growing R&D pertaining to deep brain stimulators
   4.2. Restraints
      4.2.1. Higher cost of research and development
      4.2.2. Risk of allergic reaction to the DMS parts in case of DMS placement
      4.2.3. Increased risk of infection
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of deep brain stimulator
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Deep Brain Stimulator Market, By Type
   5.1. Single Channel Deep Brain Stimulator
   5.2. Dual Channel Deep Brain Stimulator
6. Deep Brain Stimulator Market, By Application
   6.1. Pain Management
   6.2. Epilepsy
   6.3. Essential Tremor
   6.4. Obsessive Compulsive Disorder
   6.5. Depression
   6.6. Dystonia
   6.7. Parkinsons Disease
7. Deep Brain Stimulator Market, By End-User
   7.1. Hospitals
   7.2. Ambulatory Surgical Centers
   7.3. Neurological Clinics
8. Deep Brain Stimulator Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Deep Brain Stimulator – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   10.1. St. Jude Medical
   10.2. Boston scientific
   10.3. Functional Neuromodulation
   10.4. Medtronic INC.
   10.5. Aleva Neurotherapeutics SA
   10.6. Cyberonics
   10.7. ElectroCore Medical
   10.8. EnteroMedics
   10.9. Medtronic
   10.10. NEUROMetrix
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll